{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Coronavirus 3C proteases", "Drug development", "Medicinal plants", "Plant-derived compounds", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35985974", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "08"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1016/j.joim.2022.08.001", "S2095-4964(22)00089-9"], "Journal": {"ISSN": "2095-4964", "JournalIssue": {"Volume": "20", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Journal of integrative medicine", "ISOAbbreviation": "J Integr Med"}, "ArticleTitle": "Potential medicinal plants involved in inhibiting 3CL<sup>pro</sup> activity: A practical alternate approach to combating COVID-19.", "Pagination": {"StartPage": "488", "EndPage": "496", "MedlinePgn": "488-496"}, "Abstract": {"AbstractText": ["At present, a variety of vaccines have been approved, and existing antiviral drugs are being tested to find an effective treatment for coronavirus disease 2019 (COVID-19). However, no standardized treatment has yet been approved by the World Health Organization. The virally encoded chymotrypsin-like protease (3CL<sup>pro</sup>) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which facilitates the replication of SARS-CoV in the host cells, is one potential pharmacological target for the development of anti-SARS drugs. Online search engines, such as Web of Science, Google Scholar, Scopus and PubMed, were used to retrieve data on the traditional uses of medicinal plants and their inhibitory effects against the SARS-CoV 3CL<sup>pro</sup>. Various pure compounds, including polyphenols, terpenoids, chalcones, alkaloids, biflavonoids, flavanones, anthraquinones and glycosides, have shown potent inhibition of SARS-CoV-2 3CL<sup>pro</sup> activity with 50% inhibitory concentration (IC<sub>50</sub>) values ranging from 2-44\u00a0\u00b5g/mL. Interestingly, most of these active compounds, including xanthoangelol E (isolated from Angelica keiskei), dieckol 1 (isolated from Ecklonia cava), amentoflavone (isolated from Torreya nucifera), celastrol, pristimerin, tingenone and iguesterin (isolated from Tripterygium regelii), tannic acid (isolated from Camellia sinensis), and theaflavin-3,3'-digallate, 3-isotheaflav1in-3 gallate and dihydrotanshinone I (isolated from Salvia miltiorrhiza), had IC<sub>50</sub> values of less than 15\u00a0\u00b5g/mL. Kinetic mechanistic studies of several active compounds revealed that their mode of inhibition was dose-dependent and competitive, with K<sub>i</sub> values ranging from 2.4-43.8\u00a0\u03bcmol/L. Given the significance of plant-based compounds and the many promising results obtained, there is still need to explore the phytochemical and mechanistic potentials of plants and their products. These medicinal plants could serve as an effective inexpensive nutraceutical for the general public to help manage COVID-19."], "CopyrightInformation": "Copyright \u00a9 2022 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Medical Center of General Practice, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu 610041, Sichuan Province, China."}], "LastName": "Yang", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Medical Center of General Practice, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu 610041, Sichuan Province, China. Electronic address: jxlljy2011@163.com."}], "LastName": "Jiang", "ForeName": "Xiao-Lan", "Initials": "XL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830041, Xinjiang Uygur Autonomous Region, China. Electronic address: akash.malik786@mails.ucas.ac.cn."}], "LastName": "Tariq", "ForeName": "Akash", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, University of Veterinary and Animal Sciences, Ravi Campus, Pattoki 55300, Pakistan."}], "LastName": "Sadia", "ForeName": "Sehrish", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830041, Xinjiang Uygur Autonomous Region, China."}], "LastName": "Ahmed", "ForeName": "Zeeshan", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Consejo Superior de Investigaciones Cient\u00edficas, Global Ecology Unit, Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Cient\u00edficas-Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona 08193, Catalonia, Spain; Centre for Ecological Research and Forestry Applications, Cerdanyola del Vall\u00e8s 08193, Catalonia, Spain."}], "LastName": "Sardans", "ForeName": "Jordi", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, University of Veterinary and Animal Sciences, Ravi Campus, Pattoki 55300, Pakistan."}], "LastName": "Aleem", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Ullah", "ForeName": "Riaz", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ethnobotany, Institute of Botany, llia State University, Tbilisi 0105, Georgia."}], "LastName": "Bussmann", "ForeName": "Rainer W", "Initials": "RW"}], "PublicationTypeList": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "J Integr Med", "NlmUniqueID": "101603118"}, "ChemicalList": [{"RegistryNumber": "28ZK7PR57S", "NameOfSubstance": "celastrol methyl ester"}, {"RegistryNumber": "562G9360V6", "NameOfSubstance": "dihydrotanshinone I"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jiang S., Shi Z., Shu Y., Song J., Gao G.F., Tan W., et al. A distinct name is needed for the new coronavirus. Lancet. 2020;395(10228):949.", "ArticleIdList": ["PMC7124603", "32087125"]}, {"Citation": "Wu X., Mao R., Guo X. Equilibrium of tiered healthcare resources during the COVID-19 pandemic in China: a case study of Taiyuan, Shanxi Province. Int J Environ Res Public Health. 2022;19(12):7035.", "ArticleIdList": ["PMC9222232", "35742282"]}, {"Citation": "Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u2013273.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "Cele S., Jackson L., Khoury D.S., Khan K., Moyo-Gwete T., Tegally H., et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. 2022;602(7898):654\u2013656.", "ArticleIdList": ["PMC8866126", "35016196"]}, {"Citation": "Davies N.G., Abbott S., Barnard R.C., Jarvis C.I., Kucharski A.J., Munday J.D., et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538)", "ArticleIdList": ["PMC8128288", "33658326"]}, {"Citation": "Zhou D., Dejnirattisai W., Supasa P., Liu C., Mentzer A.J., Ginn H.M., et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021;184(9):2348\u20132361.e6.", "ArticleIdList": ["PMC7901269", "33730597"]}, {"Citation": "Srivastava S., Banu S., Singh P., Sowpati D.T., Mishra R.K. SARS-CoV-2 genomics: an Indian perspective on sequencing viral variants. J Biosci. 2021;46(1):22.", "ArticleIdList": ["PMC7895735", "33737495"]}, {"Citation": "Hui K.P.Y., Ho J.C.W., Cheung M.C., Ng K.C., Ching R.H.H., Lai K.L., et al. SARS-CoV-2 omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715\u2013720.", "ArticleIdList": ["35104836"]}, {"Citation": "Schultz D.C., Johnson R.M., Ayyanathan K., Miller J., Whig K., Kamalia B., et al. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature. 2022;604(7904):134\u2013140.", "ArticleIdList": ["35130559"]}, {"Citation": "Yang F., Zhang Y., Tariq A., Jiang X., Ahmed Z., Zhihao Z., et al. Food as medicine: a possible preventive measure against coronavirus disease (COVID-19) Phytother Res. 2020;34(12):3124\u20133136.", "ArticleIdList": ["PMC7283886", "32468635"]}, {"Citation": "Salehi B., Konovalov D.A., Fru P., Kapewangolo P., Peron G., Ksenija M.S., et al. Areca catechu\u2014from farm to food and biomedical applications. Phytother Res. 2020;34(9):2140\u20132158.", "ArticleIdList": ["32159263"]}, {"Citation": "Chan K.W., Wong V.T., Tang S.C.W. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med. 2020;48(3):737\u2013762.", "ArticleIdList": ["32164424"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277.", "ArticleIdList": ["PMC7128376", "32278175"]}, {"Citation": "Xu J., Zhang Y. Traditional Chinese medicine treatment of COVID-19. Compl Ther Clin Pract. 2020;39:101165.", "ArticleIdList": ["PMC7118627", "32379692"]}, {"Citation": "Aldwihi L.A., Khan S.I., Alamri F.F., AlRuthia Y., Alqahtani F., Fantoukh O.I., et al. Patients\u2019 behavior regarding dietary or herbal supplements before and during COVID-19 in Saudi Arabia. Int J Environ Res Publ Health. 2021;18(10):5086.", "ArticleIdList": ["PMC8151200", "34064950"]}, {"Citation": "Liu D.X., Fung T.S., Chong K.L., Shukla A., Hilgenfeld R. Accessory proteins of SARS-CoV and other coronaviruses. Antivir Res. 2014;109:97\u2013109.", "ArticleIdList": ["PMC7113789", "24995382"]}, {"Citation": "Vardhan S., Sahoo S.K. In silico ADMET and molecular docking study on searching potential inhibitors from limnoids and triterpenoids for COVID-19. Comput Biol Med. 2020;124:103936.", "ArticleIdList": ["PMC7386496", "32738628"]}, {"Citation": "Vardhan S., Sahoo S.K. Computational studies on the interaction of SARS-CoV-2 omicron SGp RBD with human receptors ACE2, limonin and glycyrrhizic acid. Comput Biol Med. 2022;144:105367.", "ArticleIdList": ["PMC8886687", "35247766"]}, {"Citation": "Lu C.C., Chen M.Y., Lee W.S., Chang Y.L. Potential therapeutic agents against COVID-19: what we know so far. J Chin Med Assoc. 2020;83(6):534\u2013536.", "ArticleIdList": ["PMC7176266", "32243270"]}, {"Citation": "Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313\u2013319.", "ArticleIdList": ["PMC7156227", "32296570"]}, {"Citation": "Banerjee R., Perera L., Tillekeratne L.M.V. Potential SARS-CoV-2 main protease inhibitors. Drug Discov. 2021;26(3):804\u2013816.", "ArticleIdList": ["PMC7724992", "33309533"]}, {"Citation": "Ni L., Ye F., Cheng M.L., Feng Y., Deng Y.Q., Zhao H., et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52(6):971\u2013977.e3.", "ArticleIdList": ["PMC7196424", "32413330"]}, {"Citation": "Xiang F., Wang X., He X., Peng Z., Yang B., Zhang J., et al. Antibody detection and dynamic characteristics in patients with COVID-19. Clin Infect Dis. 2020;71(8):1930\u20131934.", "ArticleIdList": ["PMC7188146", "32306047"]}, {"Citation": "Du L., Xie Y., Zheng K., Wang N., Gao M., Yu T., et al. Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication. Redox Biol. 2021;48:102199.", "ArticleIdList": ["PMC8616692", "34847508"]}, {"Citation": "Mahase E. COVID-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;375", "ArticleIdList": ["34750163"]}, {"Citation": "Abe K., Kabe Y., Uchiyama S., Iwasaki Y.W., Ishizu H., Uwamino Y., et al. Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19. Sci Rep. 2022;12(1):1299.", "ArticleIdList": ["PMC8789791", "35079088"]}, {"Citation": "Abdelnabi R., Foo C.S., Jochmans D., Vangeel L., De Jonghe S., Augustijns P., et al. The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern. Nat Commun. 2022;13(1):719.", "ArticleIdList": ["PMC8847371", "35169114"]}, {"Citation": "Hsu J.A., Kuo C.J., Hsieh H.P., Wang Y.C., Huang K.K., Lin C.C., et al. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. FEBS Lett. 2004;574(1\u20133):116\u2013120.", "ArticleIdList": ["PMC7134601", "15358550"]}, {"Citation": "Karges J., Cohen S.M. Metal complexes as antiviral agents for SARS-CoV. ChemBioChem. 2021;22(16):2600\u20132607.", "ArticleIdList": ["PMC8239769", "34002456"]}, {"Citation": "Karges J., Kalaj M., Gembicky M., Cohen S.M. ReI tricarbonyl complexes as coordinate covalent inhibitors for the SARS-CoV-2 main cysteine protease. Angew Chem Int Ed Engl. 2021;60(19):10716\u201310723.", "ArticleIdList": ["PMC8014511", "33606889"]}, {"Citation": "Park J.Y., Jeong H.J., Kim Y.M., Park S.J., Rho M.C., Park K.H., et al. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition. Bioorg Med Chem Lett. 2011;21(18):5602\u20135604.", "ArticleIdList": ["21824777"]}, {"Citation": "Park J.Y., Ko J.A., Kim D.W., Kim Y.M., Kwon H.J., Jeong H.J., et al. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem. 2016;31(1):23\u201330.", "ArticleIdList": ["25683083"]}, {"Citation": "Chen C.N., Lin C.P.C., Huang K.K., Chen W.C., Hsieh H.P., Liang P.H., et al. Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3\u2019-digallate (TF3) Evid Based Complement Alternat Med. 2005;2(2):209\u2013215.", "ArticleIdList": ["PMC1142193", "15937562"]}, {"Citation": "Wen C.C., Shyur L.F., Jan J.T., Liang P.H., Kuo C.J., Arulselvan P., et al. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J Trad Complem Med. 2011;1(1):41\u201350.", "ArticleIdList": ["PMC3942999", "24716104"]}, {"Citation": "Jamiu A.T., Aruwa C.E., Abdulakeem I.A., Ayokun-nun Ajao A., Sabiu S. Phytotherapeutic evidence against coronaviruses and prospects for COVID-19. Pharmacogn J. 2020;12(6):1252\u20131267."}, {"Citation": "Wen C.C., Kuo Y.H., Jan J.T., Liang P.H., Wang S.Y., Liu H.G., et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007;50(17):4087\u20134095.", "ArticleIdList": ["17663539"]}, {"Citation": "Park J.Y., Kim J.H., Kwon J.M., Kwon H.J., Jeong H.J., Kim Y.M., et al. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from edible brown algae Ecklonia cava. Bioorg Med Chem. 2013;21(13):3730\u20133737.", "ArticleIdList": ["PMC7126891", "23647823"]}, {"Citation": "Lau K.M., Lee K.M., Koon C.M., Cheung C.F., Lau C.P., Ho H.M., et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol. 2008;118(1):79\u201385.", "ArticleIdList": ["PMC7126383", "18479853"]}, {"Citation": "Lin C.W., Tsai F.J., Tsai C.H., Lai C.C., Wan L., Ho T.Y., et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68(1):36\u201342.", "ArticleIdList": ["PMC7114321", "16115693"]}, {"Citation": "Gong S.J., Su X.J., Yu H.P., Li J., Qin Y.J., Xu Q., et al. A study on anti-SARS-CoV 3CL protein of flavonoids from Litchi chinensis Sonn core. Zhongguo Yao Li Xue Tong Bao. 2008;24(5):699\u2013700."}, {"Citation": "Tian Y.Q., Zhang C.Y., Guo M.Q. Comparative analysis of Amaryllidaceae alkaloids from three Lycoris species. Molecules. 2015;20(12):21854\u201321869.", "ArticleIdList": ["PMC6332018", "26690108"]}, {"Citation": "Li S., Chen C., Zhang H., Guo H., Wang H., Wang L., et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67(1):18\u201323.", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Luo W., Su X., Gong S., Qin Y., Liu W., Li J., et al. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci Trends. 2009;3(4):124\u2013126.", "ArticleIdList": ["20103835"]}, {"Citation": "Park J.-Y., Kim J.H., Kim Y.M., Jeong H.J., Kim D.W., Park K.H., et al. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg Med Chem. 2012;20(19):5928\u20135935.", "ArticleIdList": ["PMC7127169", "22884354"]}, {"Citation": "Ryu Y.B., Jeong H.J., Kim J.H., Kim Y.M., Park J.-Y., Kim D., et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg Med Chem. 2010;18(22):7940\u20137947.", "ArticleIdList": ["PMC7126309", "20934345"]}, {"Citation": "Ryu Y.B., Park S.J., Kim Y.M., Lee J.Y., Seo W.D., Chang J.S., et al. SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorg Med Chem Lett. 2010;20(6):1873\u20131876.", "ArticleIdList": ["PMC7127101", "20167482"]}, {"Citation": "Akihisa T., Tokuda H., Ukiya M., Iizuka M., Schneider S., Ogasawara K., et al. Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects. Cancer Lett. 2003;201(2):133\u2013137.", "ArticleIdList": ["14607326"]}, {"Citation": "Akihisa T., Tokuda H., Hasegawa D., Ukiya M., Kimura Y., Enjo F., et al. Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J Nat Prod. 2006;69(1):38\u201342.", "ArticleIdList": ["16441065"]}, {"Citation": "Nishimura R., Tabata K., Arakawa M., Ito Y., Kimura Y., Akihisa T., et al. Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma. Biol Pharm Bull. 2007;30(10):1878\u20131883.", "ArticleIdList": ["17917255"]}, {"Citation": "Gardner E.J., Ruxton C.H., Leeds A.R. Black tea\u2014helpful or harmful? A review of the evidence. Eur J Clin Nutr. 2007;61(1):3\u201318.", "ArticleIdList": ["16855537"]}, {"Citation": "Prasanth M.I., Sivamaruthi B.S., Chaiyasut C., Tencomnao T. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019;11(2):474.", "ArticleIdList": ["PMC6412948", "30813433"]}, {"Citation": "Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea\u2014a review. J Am Coll Nutr. 2006;25(2):79\u201399.", "ArticleIdList": ["16582024"]}, {"Citation": "Hayat K., Iqbal H., Malik U., Bilal U., Mushtaq S. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2015;55(7):939\u2013954.", "ArticleIdList": ["24915350"]}, {"Citation": "Xu J., Xu Z., Zheng W. A review of the antiviral role of green tea catechins. Molecules. 2017;22(8):1337.", "ArticleIdList": ["PMC6152177", "28805687"]}, {"Citation": "Hong E.J., Na K.J., Choi I.G., Choi K.C., Jeung E.B. Antibacterial and antifungal effects of essential oils from coniferous trees. Biol Pharm Bull. 2004;27(6):863\u2013866.", "ArticleIdList": ["15187434"]}, {"Citation": "Yang J.K., Choi M.S., Seo W.T., Rinker D.L., Han S.W., Cheong G.W. Chemical composition and antimicrobial activity of Chamaecyparis obtusa leaf essential oil. Fitoterapia. 2007;78(2):149\u2013152.", "ArticleIdList": ["17161919"]}, {"Citation": "Lee G.S., Hong E.J., Gwak K.S., Park M.J., Choi K.C., Choi I.G., et al. The essential oils of Chamaecyparis obtusa promote hair growth through the induction of vascular endothelial growth factor gene. Fitoterapia. 2010;81(1):17\u201324.", "ArticleIdList": ["19576968"]}, {"Citation": "Kuo Y.C., Kuo Y.H., Lin Y.L., Tsai W.J. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interrupting the immediate-early gene expression. Antiviral Res. 2006;70:112\u2013120.", "ArticleIdList": ["16540181"]}, {"Citation": "Jung W.K., Heo S.J., Jeon Y.J., Lee C.M., Park Y.M., Byun H.G., et al. Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells. J Agric Food Chem. 2009;57(10):4439\u20134446.", "ArticleIdList": ["19408937"]}, {"Citation": "EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Turck D., Bresson J.L., Burlingame B., Dean T., Fairweather-Tait S., et al. Scientific opinion on the safety of Ecklonia cava phlorotannins as a novel food pursuant to Regulation (EC) No 258/97. EFSA J. 2017;15(10):e5003.", "ArticleIdList": ["PMC7010033", "32625298"]}, {"Citation": "Kim K.N., Heo S.J., Yoon W.J., Kang S.M., Ahn G., Yi T.H., et al. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-\u03baB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur J Pharmacol. 2010;649(1\u20133):369\u2013375.", "ArticleIdList": ["20868674"]}, {"Citation": "Lee S.H., Li Y., Karadeniz F., Kim M.M., Kim S.K. \u03b1-Glucosidase and \u03b1-amylase inhibitory activities of phloroglucinal derivatives from edible marine brown alga, Ecklonia cava. J Sci Food Agric. 2009;89(9):1552\u20131558."}, {"Citation": "Choi J.G., Kang O.H., Brice O.O., Lee Y.S., Chae H.S., Oh Y.C., et al. Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp. Foodborn Pathog Dis. 2010;7(4):435\u2013441.", "ArticleIdList": ["20001325"]}, {"Citation": "Bais S, Gill NS, Rana N, Shandil, S. A phytopharmacological review on a medicinal plant: Juniperus communis. Int Sch Res Notices 2014;2014:634723.", "ArticleIdList": ["PMC4897106", "27419205"]}, {"Citation": "Lu H.M., Liang Y.Z., Yi L.Z., Wu X.J. Anti-inflammatory effect of Houttuynia cordata injection. J Ethnopharmacol. 2006;104(1\u20132):245\u2013249.", "ArticleIdList": ["PMC7127264", "16213118"]}, {"Citation": "Chiang L.C., Chang J.S., Chen C.C., Ng L.T., Lin C.C. Anti-herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am J Chin Med. 2003;31(3):355\u2013362.", "ArticleIdList": ["12943167"]}, {"Citation": "Kim S.K., Ryu S.Y., No J., Choi S.U., Kim Y.S. Cytotoxic alkaloids from Houttuynia cordata. Arch Pharm Res. 2001;24(6):518\u2013521.", "ArticleIdList": ["11794526"]}, {"Citation": "Wu Z., Deng X., Hu Q., Xiao X., Jiang J., Ma X., et al. Houttuynia cordata Thunb: an ethnopharmacological review. Front Pharmacol. 2021;12:714694.", "ArticleIdList": ["PMC8440972", "34539401"]}, {"Citation": "Qin G.W., Xu R.S. Recent advances on bioactive natural products from Chinese medicinal plants. Med Res Rev. 1998;18(6):375\u2013382.", "ArticleIdList": ["9828038"]}, {"Citation": "Gilbert K.G., Maule H.G., Rudolph B., Lewis M., Vandenburg H., Sales E., et al. Quantitative analysis of indigo and indigo precursors in leaves of Isatis spp. and Polygonum tinctorium. Biotechnol Prog. 2004;20(4):1289\u20131292.", "ArticleIdList": ["15296465"]}, {"Citation": "Heredia A., Davis C., Bamba D., Le N., Gwarzo M.Y., Sadowska M., et al. Indirubin-3-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. AIDS. 2005;19(18):2087\u20132095.", "ArticleIdList": ["16284457"]}, {"Citation": "Ji Y.B., Wu D., Dai Q.C., Guo L., Chen N. The research on the medicinal value of Amaryllidaceae plants. Appl Mech Mater. 2013;411\u2013414:3223\u20133226."}, {"Citation": "Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., et al. High throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J Virol. 2019;93(12) e00023\u201319.", "ArticleIdList": ["PMC6613765", "30918074"]}, {"Citation": "Liu J., Yang Y., Xu Y., Ma C., Qin C., Zhang L. Lycorine reduces mortality of human entero virus 71-infected mice by inhibiting virus replication. Virol J. 2011;8:483\u2013489.", "ArticleIdList": ["PMC3212826", "22029605"]}, {"Citation": "Zhou L., Zuo Z., Chow M.S.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2005;45(12):1345\u20131359.", "ArticleIdList": ["16291709"]}, {"Citation": "Wang B.Q. Salvia miltiorrhiza: chemical and pharmacological review of a medicinal plant. J Med Plants Res. 2010;4(25):2813\u20132820."}, {"Citation": "Abd-Elazem I.S., Chen H.S., Bates R.B., Huang R.C.C. Isolation of two highly potent and non-toxic inhibitors of human immuno-deficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza. Antiviral Res. 2002;55(1):91\u2013106.", "ArticleIdList": ["12076754"]}, {"Citation": "Lee E.S., Kim M.S., Weeratunga P., Lee H.C., Chathuranga K., Ma J.Y., et al. The anti-influenza effect of a water soluble herbal extract from Salvia miltiorrhiza (Danshen) in vivo. J Biomed Trans Res. 2018;19(1):21\u201325."}, {"Citation": "Wu B.W., Pan T.L., Leu Y.L., Chang Y.K., Tai P.J., Lin K.H., et al. Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am J Chin Med. 2007;35(01):153\u2013168.", "ArticleIdList": ["17265559"]}, {"Citation": "Ma B., Hu T., Li P., Yuan Q., Lin Z., Tu Y., et al. Phylogeographic and phylogenetic analysis for Tripterygium species delimitation. Ecol Evol. 2017;7(20):8612\u20138623.", "ArticleIdList": ["PMC5648662", "29075476"]}, {"Citation": "Liu Q. Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol. 2011;11(3):377\u2013383.", "ArticleIdList": ["21255694"]}, {"Citation": "Hayashi K., Hayashi T., Ujita K., Takaishi Y. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2. J Antimicrob Chemother. 1996;37(4):759\u2013768.", "ArticleIdList": ["8722541"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "27"}, {"Year": "2022", "Month": "6", "Day": "29"}, {"Year": "2022", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "19", "Hour": "22", "Minute": "9"}, {"Year": "2022", "Month": "8", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35985974", "PMC9359926", "10.1016/j.joim.2022.08.001", "S2095-4964(22)00089-9"]}}], "PubmedBookArticle": []}